Antiviral treatment for preventing postherpetic neuralgia

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2007, Pages

  Li, Q ^b   He, Li ^a   Zhang, Q ^b   Zhou, M ^b   Zhou, D ^b  

^a SICHUAN UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; FAMCICLOVIR; GABAPENTIN; LIDOCAINE; OPIATE; PLACEBO; PREGABALIN; VALACICLOVIR; VARICELLA ZOSTER VACCINE;

ATTRIBUTABLE RISK; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; DATA EXTRACTION; DISEASE SEVERITY; DRUG EFFICACY; HOSPITALIZATION; HUMAN; PAIN ASSESSMENT; POSTHERPETIC NEURALGIA; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME; VARICELLA ZOSTER VIRUS;

EID: 44949093551     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006866     Document Type: Review

References (29)

1. Alper 2000 Alper BS, Lewis PR. Does treatment of acute herpes zoster prevent or shorten postherpetic neuralgia?. Journal of Family Practice 2000;49(3):255-64.
2. Attal 2006 Attal N, Cruccu G, Haanpaa M, Hansson P, Jensen TS, Nurmikko T, et al.EFNS guidelines on pharmacological treatment of neuropathic pain. European Journal of Neurology 2006;13(17):1153-69.
3. Desmond 2002 Desmond RA, Weiss HL, Arani RB, Soong SJ, Wood MJ, Fiddian PA, et al.Clinical applications for change-point analysis of herpes zoster pain. Journal of Pain and Symptom Management 2002;23(6): 510-6.
4. Dubinsky 2004 Dubinsky RM, Kabbani H, El-Chami Z, Boutwell C, Ali H. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004;63(6):959-65.
5. Dworkin 1994 Dworkin RH, Portenoy RK. Proposed classification of herpes zoster pain. Lancet 1994;343(8913):1648.
6. Dworkin 2001 Dworkin RH, Schmader KE. Epidemiology and natural history of herpes zoster and postherpetic neuralgia. Herpes zoster and postherpetic neuralgia. 2nd Edition. New York: Elsevier Press, 2001:39-64.
7. Fillet 2002 Fillet AM. Prophylaxis of herpesvirus infections in immunocompetent and immunocompromised older patients. Drugs & Aging 2002;19(5):343-54.
8. Gnann 2002 Gnann JW Jr, Whitley RJ. Clinical practice. Herpes zoster. New England Journal of Medicine 2002;347(5):340-6.
9. Hempenstall 2005 Hempenstall K, Nurmikko TJ, Johnson RW, A'Hern RP, Rice AS. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Medicine / Public Library of Science 2005;2(7):e164.
10. Higgins 2002 Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21(11):1539-58.
11. Higgins 2003 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557- 60.
12. Higgins 2005 Higgins JP, Green S, editors. MEDLINE highly sensitive search strategy. Cochrane handbook for systematic reviews of interventions 4.2.5 [updated March 2005]. www.cochrane.org/resources/handbook/ hbook.htm accessed 31 May 2005.
13. Jackson 1997 Jackson JL, Gibbons R, Meyer G, Inouye L. The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia. A meta-analysis. Archives of Internal Medicine 1997;157(8):909-12.
14. Kost 1996 Kost RG, Straus SE. Postherpetic neuralgia - pathogenesis, treatment, and prevention. The New England Journal of Medicine 1996;335(1):32-42.
15. Lancaster 1995 Lancaster T, Silagy C, Gray S. Primary care management of acute herpes zoster: systematic review of evidence from randomized controlled trials. British Journal of General Practice 1995;45(390):39-45.
16. MacDonald 2000 MacDonald BK, Cockerell OC, Sander JW, Shorvon SD. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000;123(Pt 4):665-76.
17. Mahalingam 1995 Mahalingam R, Wellish M, Brucklier J, Gilden DH. Persistence of varicella-zoster virus DNA in elderly patients with postherpetic neuralgia. Journal of Neurovirology 1995;1(1):130-3.
18. Meyler 2000 Dukes MNG, Aronson JK (eds). Meyler's Side Effects of Drugs. 14th Edition. Amsterdam: Elsevier, 2000.
19. Oxman 2005 Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al.A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. The New England Journal of Medicine 2005;352(22): 2271-84.
20. Portenoy 1986 Portenoy RK, Duma C, Foley KM. Acute herpetic and postherpetic neuralgia: clinical review and current management. Annals of Neurology 1986;20(6):651-64.
21. Schmader 2002 Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. The Clinical Journal of Pain 2002;18(6):350-4.
22. Smith 1978 Smith FP. Pathological studies of spinal nerve ganglia in relation to intractable intercostal pain. Surgical Neurology 1978;10(1):50-3.
23. Stankus 2000 Stankus SJ, Dlugopolski M, Packer D. Management of herpes zoster (shingles) and postherpetic neuralgia. American Family Physician 2000;61(8):2437-44, 2447-8.
24. Stratton Hill 1997 Stratton Hill C. Guidelines for Treatment of Cancer Pain: The Revised Pocket Edition of the Final Report of the Texas Cancer Council's Work-group on Pain Control in Cancer Patients. 2nd Edition. Texas Cancer Council, 1997:61-63.
25. Thyregod 2007 Thyregod HG, Rowbotham MC, Peters M, Possehn J, Berro M, Petersen KL. Natural history of pain following herpes zoster. Pain 2007;128(1-2):148-56.
26. Vafai 1988 Vafai A, Wellish M, Gilden DH. Expression of varicella-zoster virus in blood mononuclear cells of patients with postherpetic neuralgia. Proceedings of the National Academy of Sciences of the United States of America 1988;85(8):2767-70.
27. Ware 1998 Ware JE, Gandek B. Overview of the SF-36 Heath-Survey and the International Quality of Life Assesment (IQOLA) Project. Journal of Clinical Epidemiology 1998;51(11):903-12.
28. Watson 1991 Watson CP, Deck JH, Morshead C, Van der Kooy D, Evans RJ. Postherpetic neuralgia: further post-mortem studies of cases with and without pain. Pain 1991;44(2):105-17.
29. Wood 1996 Wood MJ, Kay R, Dworkin RH, Soong SJ, Whitley RJ. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clinical Infectious Diseases 1996;22(2):341-7.